Detalhe da pesquisa
1.
A multicentre, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozin.
Diabetes Obes Metab
; 26(6): 2188-2198, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38425186
2.
Efficacy and safety of monotherapy with enavogliflozin in Korean patients with type 2 diabetes mellitus: Results of a 12-week, multicentre, randomized, double-blind, placebo-controlled, phase 2 trial.
Diabetes Obes Metab
; 25(8): 2096-2104, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37016484
3.
Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study.
Diabetes Obes Metab
; 25(9): 2743-2755, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37337747
4.
Efficacy and safety of fixed-dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double-blind, controlled, phase 3 trial.
Diabetes Obes Metab
; 21(1): 103-111, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30084112
5.
A 52-week extension study of switching from gemigliptin vs sitagliptin to gemigliptin only as add-on therapy for patients with type 2 diabetes who are inadequately controlled with metformin alone.
Diabetes Obes Metab
; 20(6): 1535-1541, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29436761
6.
Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types.
Support Care Cancer
; 25(3): 801-809, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27826874
7.
Reduction in microalbuminuria by calcium channel blockers in patients with type 2 diabetes mellitus and hypertension-A randomized, open-label, active-controlled, superiority, parallel-group clinical trial.
Int J Clin Pract
; 71(9)2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-28840637
8.
Effects of Elastic Band Resistance Training on Glucose Control, Body Composition, and Physical Function in Women With Short- vs. Long-Duration Type-2 Diabetes.
J Strength Cond Res
; 30(6): 1688-99, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-26562712
9.
A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise.
Diabetes Metab Res Rev
; 31(3): 295-306, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25362864
10.
A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetes.
Endocr J
; 62(5): 449-62, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25819061
11.
Efficacy and Safety of Alogliptin-Pioglitazone Combination for Type 2 Diabetes Mellitus Poorly Controlled with Metformin: A Multicenter, Double-Blind Randomized Trial.
Diabetes Metab J
; 2024 Apr 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38650099
12.
Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study.
Adv Ther
; 41(5): 1967-1982, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38512540
13.
The Efficacy and Tolerability of Irbesartan/Amlodipine Combination Therapy in Patients With Essential Hypertension Whose Blood Pressure Were not Controlled by Irbesartan Monotherapy.
Clin Ther
; 2024 May 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38704294
14.
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial.
Diabetes Metab J
; 2024 May 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38763510
15.
The effects of caloric restriction on fetuin-A and cardiovascular risk factors in rats and humans: a randomized controlled trial.
Clin Endocrinol (Oxf)
; 79(3): 356-63, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23067229
16.
Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors.
Adv Ther
; 40(11): 4817-4835, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37651078
17.
Erratum to: Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types.
Support Care Cancer
; 25(5): 1741, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28197847
18.
Effects of pinitol on glycemic control, insulin resistance and adipocytokine levels in patients with type 2 diabetes mellitus.
Ann Nutr Metab
; 60(1): 1-5, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22179130
19.
Effect of Dapagliflozin as an Add-on Therapy to Insulin on the Glycemic Variability in Subjects with Type 2 Diabetes Mellitus (DIVE): A Multicenter, Placebo-Controlled, Double-Blind, Randomized Study.
Diabetes Metab J
; 45(3): 339-348, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32602273
20.
A Multicentre, Multinational, Open-Label, 52-Week Extension Study of Gemigliptin (LC15-0444) Monotherapy in Patients with Type 2 Diabetes Mellitus.
Diabetes Metab J
; 45(4): 606-612, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33081425